543 related articles for article (PubMed ID: 23497468)
1. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
2. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
3. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
4. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
[TBL] [Abstract][Full Text] [Related]
5. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
6. Plasma sex steroid hormones and breast cancer risk in Chinese women.
Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
[TBL] [Abstract][Full Text] [Related]
9. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
[TBL] [Abstract][Full Text] [Related]
11. Circulating Hormones and Mammographic Density in Premenopausal Women.
Bertrand KA; Eliassen AH; Hankinson SE; Rosner BA; Tamimi RM
Horm Cancer; 2018 Apr; 9(2):117-127. PubMed ID: 29330698
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
13. Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women.
Farland LV; Mu F; Eliassen AH; Hankinson SE; Tworoger SS; Barbieri RL; Dowsett M; Pollak MN; Missmer SA
Cancer Causes Control; 2017 Dec; 28(12):1441-1452. PubMed ID: 29086892
[TBL] [Abstract][Full Text] [Related]
14. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
Dorgan JF; Stanczyk FZ; Kahle LL; Brinton LA
Breast Cancer Res; 2010; 12(6):R98. PubMed ID: 21087481
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-Analysis of Smoking and Circulating Sex Hormone Levels Among Premenopausal Women.
Ihenacho U; Sriprasert I; Mack WJ; Hamilton AS; Unger JB; Press MF; Wu AH
Nicotine Tob Res; 2022 Oct; 24(11):1705-1713. PubMed ID: 35291014
[TBL] [Abstract][Full Text] [Related]
16. The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States).
Dorgan JF; Reichman ME; Judd JT; Brown C; Longcope C; Schatzkin A; Campbell WS; Franz C; Kahle L; Taylor PR
Cancer Causes Control; 1994 Jan; 5(1):53-60. PubMed ID: 8123779
[TBL] [Abstract][Full Text] [Related]
17. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.
Schernhammer ES; Sperati F; Razavi P; Agnoli C; Sieri S; Berrino F; Krogh V; Abbagnato C; Grioni S; Blandino G; Schunemann HJ; Muti P
Breast Cancer Res; 2013 Jun; 15(3):R46. PubMed ID: 23777922
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
20. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women.
Tworoger SS; Eliassen AH; Missmer SA; Baer H; Rich-Edwards J; Michels KB; Barbieri RL; Dowsett M; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2494-501. PubMed ID: 17164375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
